Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

@article{powles2026pembrolizumab,
  title = {{Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial}},
  author = {Thomas Powles and Tibor Csőszi and Mustafa Özgüroğlu and Nobuaki Matsubara and Lajos Géczi and Susanna Y-S Cheng and Yves Fradet and Stephane Oudard and Christof Vulsteke and Rafael Morales Barrera and Aude Fléchon and Seyda Gunduz and Yohann Loriot and Alejo Rodriguez-Vida and Ronac Mamtani and Evan Yu and Kijoeng Nam and Kentaro Imai and Blanca Homet Moreno and Ajjai Alva and Diana Vera Cascallar and Mirta Varela and Mauricio Fernandez Lazzaro and Diego Lucas Kaen and Gabriela Gatica and David Hugo Flores and Agustin Falco and Matias Molina and Filip van Aelst and Christof Vulsteke and Brieuc Sautois and Jean-Pascal Machiels and Denis Schallier and Leandro Brust and Liane Rapatoni and Sergio Azevedo and Gisele Marinho and Joao Paulo Holanda Soares and Carlos Dzik and Jamile Almeida Silva and Andre Poisl Fay and Joel Gingerich and Yves Fradet and Cristiano Ferrario and Kylea Potvin and Marie Vanhuyse and Mahmoud Abdelsalam and Susanna Cheng and Christian Caglevic and Felipe Reyes and Jose Luis Leal and Francisco Francisco and Carolina Ibanez and Florence Joly and Brigitte Laguerre and Sylvain Ladoire and Aude Flechon and Delphine Topart and Olivier Huillard and Stéphane Oudard},
  journal = {Lancet Oncology},
  year = {2026},
  month = sep,
  doi = {10.1016/s1470-2045(21)00152-2},
  url = {https://hal.science/hal-05742858v1},
}

TY  - JOUR
TI  - Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
AU  - Thomas Powles
AU  - Tibor Csőszi
AU  - Mustafa Özgüroğlu
AU  - Nobuaki Matsubara
AU  - Lajos Géczi
AU  - Susanna Y-S Cheng
AU  - Yves Fradet
AU  - Stephane Oudard
AU  - Christof Vulsteke
AU  - Rafael Morales Barrera
AU  - Aude Fléchon
AU  - Seyda Gunduz
AU  - Yohann Loriot
AU  - Alejo Rodriguez-Vida
AU  - Ronac Mamtani
AU  - Evan Yu
AU  - Kijoeng Nam
AU  - Kentaro Imai
AU  - Blanca Homet Moreno
AU  - Ajjai Alva
AU  - Diana Vera Cascallar
AU  - Mirta Varela
AU  - Mauricio Fernandez Lazzaro
AU  - Diego Lucas Kaen
AU  - Gabriela Gatica
AU  - David Hugo Flores
AU  - Agustin Falco
AU  - Matias Molina
AU  - Filip van Aelst
AU  - Christof Vulsteke
AU  - Brieuc Sautois
AU  - Jean-Pascal Machiels
AU  - Denis Schallier
AU  - Leandro Brust
AU  - Liane Rapatoni
AU  - Sergio Azevedo
AU  - Gisele Marinho
AU  - Joao Paulo Holanda Soares
AU  - Carlos Dzik
AU  - Jamile Almeida Silva
AU  - Andre Poisl Fay
AU  - Joel Gingerich
AU  - Yves Fradet
AU  - Cristiano Ferrario
AU  - Kylea Potvin
AU  - Marie Vanhuyse
AU  - Mahmoud Abdelsalam
AU  - Susanna Cheng
AU  - Christian Caglevic
AU  - Felipe Reyes
AU  - Jose Luis Leal
AU  - Francisco Francisco
AU  - Carolina Ibanez
AU  - Florence Joly
AU  - Brigitte Laguerre
AU  - Sylvain Ladoire
AU  - Aude Flechon
AU  - Delphine Topart
AU  - Olivier Huillard
AU  - Stéphane Oudard
PY  - 2026
DA  - 2026/09/08
JO  - Lancet Oncology
DO  - 10.1016/s1470-2045(21)00152-2
UR  - https://hal.science/hal-05742858v1
SN  - 1470-2045
SN  - 1474-5488
ER  -